PL2596794T3 - Sposób leczenia różnego pochodzenia chorób wątroby - Google Patents

Sposób leczenia różnego pochodzenia chorób wątroby

Info

Publication number
PL2596794T3
PL2596794T3 PL10797363T PL10797363T PL2596794T3 PL 2596794 T3 PL2596794 T3 PL 2596794T3 PL 10797363 T PL10797363 T PL 10797363T PL 10797363 T PL10797363 T PL 10797363T PL 2596794 T3 PL2596794 T3 PL 2596794T3
Authority
PL
Poland
Prior art keywords
liver diseases
treating liver
various origins
origins
treating
Prior art date
Application number
PL10797363T
Other languages
English (en)
Inventor
Georgy Viktorovich Tets
Viktor Veniaminovich Tets
Original Assignee
Georgy Viktorovich Tets
Viktor Veniaminovich Tets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgy Viktorovich Tets, Viktor Veniaminovich Tets filed Critical Georgy Viktorovich Tets
Publication of PL2596794T3 publication Critical patent/PL2596794T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/66Thiobarbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10797363T 2009-07-07 2010-06-04 Sposób leczenia różnego pochodzenia chorób wątroby PL2596794T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2009126442/14A RU2400233C1 (ru) 2009-07-07 2009-07-07 Способ лечения заболеваний печени различного генеза
PCT/RU2010/000291 WO2011005142A1 (ru) 2009-07-07 2010-06-04 Способ лечения заболеваний печени различного генеза
EP10797363.8A EP2596794B1 (en) 2009-07-07 2010-06-04 Method for treating liver diseases of various origins

Publications (1)

Publication Number Publication Date
PL2596794T3 true PL2596794T3 (pl) 2020-02-28

Family

ID=42940195

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10797363T PL2596794T3 (pl) 2009-07-07 2010-06-04 Sposób leczenia różnego pochodzenia chorób wątroby

Country Status (6)

Country Link
US (4) US8962640B2 (pl)
EP (1) EP2596794B1 (pl)
ES (1) ES2752900T3 (pl)
PL (1) PL2596794T3 (pl)
RU (1) RU2400233C1 (pl)
WO (1) WO2011005142A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2400233C1 (ru) 2009-07-07 2010-09-27 Общество с ограниченной ответственностью "Вирфарм" Способ лечения заболеваний печени различного генеза
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
RU2595868C1 (ru) 2015-03-27 2016-08-27 Виктор Вениаминович Тец Лекарственное средство с гепатопротекторной активностью
RU2666148C1 (ru) * 2017-10-05 2018-09-06 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения водорастворимой лиофилизированной формы соли бис(2-тио-4,6-диоксо-1,2,3,4,5,6-гексагидропиримидин-5-ил)-(4-нитрофенил)метана

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1821209C (ru) 1990-01-08 1993-06-15 Ставропольский государственный медицинский институт Способ лечени хронических заболеваний печени
RU2035906C1 (ru) 1990-05-14 1995-05-27 Григорьева Анна Саввична Способ лечения заболеваний печени различного генеза
EP1043318A4 (en) * 1997-11-19 2001-02-07 Tets Viktor Veniaminovich SALTS OF 5,5'-ARYLIDENEBISBARBITURIC ACIDS AND 5,5'-ARYLIDENEBIS (2-THIOBARBITURIC) AND 5.5'-ARYLIDENEBIS (2-THIOBARBITURIC ACIDS) HAVING ANTIBACTERIAL, ANTI-CHLAMYDIOSE AND ANTIVIRULAR ACTION
WO1999061427A1 (fr) 1998-05-26 1999-12-02 Rimma Iliinichna Ashkinazi Derives n-substitues d'acide 5-oxyiminobarbiturique
RU2188196C2 (ru) 1998-05-26 2002-08-27 Ашкинази Римма Ильинична N-замещенные производные 5-оксииминобарбитуровой кислоты
US6265578B1 (en) * 1999-02-12 2001-07-24 Hoffmann-La Roche Inc. Pyrimidine-2,4,6-triones
NZ523463A (en) 2000-07-05 2004-06-25 Biotie Therapies Corp Inhibitors of copper-containing amine oxidases
OA12528A (en) 2000-10-26 2006-06-02 Pfizer Prod Inc Pyrimidine-2,4,6-trione metalloproteinase inhibitors.
RU2317981C2 (ru) 2001-12-14 2008-02-27 Ново Нордиск А/С Соединения и их применение для снижения активности гормон-чувствительной липазы
US7067517B2 (en) 2001-12-14 2006-06-27 Nero Nordisk A/S Use of compounds for decreasing activity of hormone-sensitive lipase
WO2009059941A1 (de) 2007-11-06 2009-05-14 Basf Se Verfahren zur regioselektiven alkoxyalkylierung von substituierten benzolen
RU2400233C1 (ru) * 2009-07-07 2010-09-27 Общество с ограниченной ответственностью "Вирфарм" Способ лечения заболеваний печени различного генеза

Also Published As

Publication number Publication date
US8962640B2 (en) 2015-02-24
EP2596794A4 (en) 2015-03-25
US9730933B2 (en) 2017-08-15
RU2400233C1 (ru) 2010-09-27
EP2596794B1 (en) 2019-08-07
US20180021339A1 (en) 2018-01-25
US20160250214A1 (en) 2016-09-01
WO2011005142A1 (ru) 2011-01-13
EP2596794A1 (en) 2013-05-29
ES2752900T3 (es) 2020-04-06
US20120157483A1 (en) 2012-06-21
US10052327B2 (en) 2018-08-21
US20150158825A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
HK1217763A1 (zh) 用於治療疾病的方法
EP2313103A4 (en) PROCESS FOR TREATING A BLÉPHARITE
PT2429524T (pt) Formulação de ac220 seca por atomização
LT2268292T (lt) Vėžio gydymo būdai ir kompozicijos
HK1176870A1 (zh) 疾病的治療方法
EP2350641A4 (en) Methods of Treatment
EP2552446A4 (en) METHOD FOR TREATING SCHIZOPHRENIA AND ASSOCIATED DISEASES
IL218230A0 (en) Method of treating cancer
PL2596794T3 (pl) Sposób leczenia różnego pochodzenia chorób wątroby
EP2381774A4 (en) METHOD OF TREATING NEURODEGENERATIVE DISEASE
EP2413698A4 (en) PROCESS FOR TREATING OSTEOPOROSIS
EP2509599A4 (en) METHOD FOR THE TREATMENT OF PANCREATIC CANCER
EP2424539A4 (en) PROCESS FOR TREATING DEPRESSION
GB0921823D0 (en) Method of treatment
GB0909807D0 (en) Method of treatment
GB0904164D0 (en) Method of treatment
GB0823435D0 (en) Method of treatment
AU2009905039A0 (en) Method of treatment of liver disease